These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38981336)

  • 1. Structure-based mapping of the histone-binding pocket of KDM4D using functionalized tetrazole and pyridine core compounds.
    Małecki PH; Fassauer GM; Rüger N; Schulig L; Link A; Krylova O; Heinemann U; Weiss MS
    Eur J Med Chem; 2024 Oct; 276():116642. PubMed ID: 38981336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-Based Screening of Tetrazolylhydrazide Inhibitors versus KDM4 Histone Demethylases.
    Małecki PH; Rüger N; Roatsch M; Krylova O; Link A; Jung M; Heinemann U; Weiss MS
    ChemMedChem; 2019 Nov; 14(21):1828-1839. PubMed ID: 31475772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C8-substituted pyrido[3,4-d]pyrimidin-4(3H)-ones: Studies towards the identification of potent, cell penetrant Jumonji C domain containing histone lysine demethylase 4 subfamily (KDM4) inhibitors, compound profiling in cell-based target engagement assays.
    Le Bihan YV; Lanigan RM; Atrash B; McLaughlin MG; Velupillai S; Malcolm AG; England KS; Ruda GF; Mok NY; Tumber A; Tomlin K; Saville H; Shehu E; McAndrew C; Carmichael L; Bennett JM; Jeganathan F; Eve P; Donovan A; Hayes A; Wood F; Raynaud FI; Fedorov O; Brennan PE; Burke R; van Montfort RLM; Rossanese OW; Blagg J; Bavetsias V
    Eur J Med Chem; 2019 Sep; 177():316-337. PubMed ID: 31158747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell Penetrant Inhibitors of the KDM4 and KDM5 Families of Histone Lysine Demethylases. 1. 3-Amino-4-pyridine Carboxylate Derivatives.
    Westaway SM; Preston AG; Barker MD; Brown F; Brown JA; Campbell M; Chung CW; Diallo H; Douault C; Drewes G; Eagle R; Gordon L; Haslam C; Hayhow TG; Humphreys PG; Joberty G; Katso R; Kruidenier L; Leveridge M; Liddle J; Mosley J; Muelbaier M; Randle R; Rioja I; Rueger A; Seal GA; Sheppard RJ; Singh O; Taylor J; Thomas P; Thomson D; Wilson DM; Lee K; Prinjha RK
    J Med Chem; 2016 Feb; 59(4):1357-69. PubMed ID: 26771107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KDM4B as a target for prostate cancer: structural analysis and selective inhibition by a novel inhibitor.
    Chu CH; Wang LY; Hsu KC; Chen CC; Cheng HH; Wang SM; Wu CM; Chen TJ; Li LT; Liu R; Hung CL; Yang JM; Kung HJ; Wang WC
    J Med Chem; 2014 Jul; 57(14):5975-85. PubMed ID: 24971742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell Penetrant Inhibitors of the KDM4 and KDM5 Families of Histone Lysine Demethylases. 2. Pyrido[3,4-d]pyrimidin-4(3H)-one Derivatives.
    Westaway SM; Preston AG; Barker MD; Brown F; Brown JA; Campbell M; Chung CW; Drewes G; Eagle R; Garton N; Gordon L; Haslam C; Hayhow TG; Humphreys PG; Joberty G; Katso R; Kruidenier L; Leveridge M; Pemberton M; Rioja I; Seal GA; Shipley T; Singh O; Suckling CJ; Taylor J; Thomas P; Wilson DM; Lee K; Prinjha RK
    J Med Chem; 2016 Feb; 59(4):1370-87. PubMed ID: 26771203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structures of two inhibitors in complex with histone lysine demethylase 4D (KDM4D) provide new insights for rational drug design.
    Wang T; Liu Y; Zhang H; Fang Z; Zhang R; Zhang W; Fan Y; Xiang R
    Biochem Biophys Res Commun; 2021 May; 554():71-75. PubMed ID: 33780862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative high-throughput screening identifies 8-hydroxyquinolines as cell-active histone demethylase inhibitors.
    King ON; Li XS; Sakurai M; Kawamura A; Rose NR; Ng SS; Quinn AM; Rai G; Mott BT; Beswick P; Klose RJ; Oppermann U; Jadhav A; Heightman TD; Maloney DJ; Schofield CJ; Simeonov A
    PLoS One; 2010 Nov; 5(11):e15535. PubMed ID: 21124847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tetrazolylhydrazides as Selective Fragment-Like Inhibitors of the JumonjiC-Domain-Containing Histone Demethylase KDM4A.
    Rüger N; Roatsch M; Emmrich T; Franz H; Schüle R; Jung M; Link A
    ChemMedChem; 2015 Nov; 10(11):1875-83. PubMed ID: 26337137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysine-241 Has a Role in Coupling 2OG Turnover with Substrate Oxidation During KDM4-Catalysed Histone Demethylation.
    Hancock RL; Abboud MI; Smart TJ; Flashman E; Kawamura A; Schofield CJ; Hopkinson RJ
    Chembiochem; 2018 May; 19(9):917-921. PubMed ID: 29443450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of a potent and selective inhibitor of histone lysine demethylase KDM4D.
    Fang Z; Liu Y; Zhang R; Chen Q; Wang T; Yang W; Fan Y; Yu C; Xiang R; Yang S
    Eur J Med Chem; 2021 Nov; 223():113662. PubMed ID: 34237635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanistic and structural studies of KDM-catalysed demethylation of histone 1 isotype 4 at lysine 26.
    Walport LJ; Hopkinson RJ; Chowdhury R; Zhang Y; Bonnici J; Schiller R; Kawamura A; Schofield CJ
    FEBS Lett; 2018 Oct; 592(19):3264-3273. PubMed ID: 30156264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly selective inhibition of histone demethylases by de novo macrocyclic peptides.
    Kawamura A; Münzel M; Kojima T; Yapp C; Bhushan B; Goto Y; Tumber A; Katoh T; King ON; Passioura T; Walport LJ; Hatch SB; Madden S; Müller S; Brennan PE; Chowdhury R; Hopkinson RJ; Suga H; Schofield CJ
    Nat Commun; 2017 Apr; 8():14773. PubMed ID: 28382930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benzo[
    Kim YJ; Lee DH; Choi YS; Jeong JH; Kwon SH
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31775247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the catalytic domains of multiple JmjC oxygenases using peptide substrates.
    Williams ST; Walport LJ; Hopkinson RJ; Madden SK; Chowdhury R; Schofield CJ; Kawamura A
    Epigenetics; 2014 Dec; 9(12):1596-603. PubMed ID: 25625844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of a Highly Selective Cell-Active Inhibitor of the Histone Lysine Demethylases KDM2/7.
    Gerken PA; Wolstenhulme JR; Tumber A; Hatch SB; Zhang Y; Müller S; Chandler SA; Mair B; Li F; Nijman SMB; Konietzny R; Szommer T; Yapp C; Fedorov O; Benesch JLP; Vedadi M; Kessler BM; Kawamura A; Brennan PE; Smith MD
    Angew Chem Int Ed Engl; 2017 Dec; 56(49):15555-15559. PubMed ID: 28976073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced Properties of a Benzimidazole Benzylpyrazole Lysine Demethylase Inhibitor: Mechanism-of-Action, Binding Site Analysis, and Activity in Cellular Models of Prostate Cancer.
    Carter DM; Specker E; Małecki PH; Przygodda J; Dudaniec K; Weiss MS; Heinemann U; Nazaré M; Gohlke U
    J Med Chem; 2021 Oct; 64(19):14266-14282. PubMed ID: 34555281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of a new class of JMJD6 inhibitors and structure-activity relationship study.
    Wang T; Zhang R; Liu Y; Fang Z; Zhang H; Fan Y; Yang S; Xiang R
    Bioorg Med Chem Lett; 2021 Jul; 44():128109. PubMed ID: 33991627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective inhibitors of the JMJD2 histone demethylases: combined nondenaturing mass spectrometric screening and crystallographic approaches.
    Rose NR; Woon EC; Kingham GL; King ON; Mecinović J; Clifton IJ; Ng SS; Talib-Hardy J; Oppermann U; McDonough MA; Schofield CJ
    J Med Chem; 2010 Feb; 53(4):1810-8. PubMed ID: 20088513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitor scaffold for the histone lysine demethylase KDM4C (JMJD2C).
    Leurs U; Clausen RP; Kristensen JL; Lohse B
    Bioorg Med Chem Lett; 2012 Sep; 22(18):5811-3. PubMed ID: 22917519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.